Track the Shuttle Pharmaceuticals Holdings, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was filed on 15 July 2026 (Cession). Among the most active insiders: HRT FINANCIAL LP. All data is accessible without an account.
23
Insider Decl.
n/a
Thresholds
€50,766
3 ops.
Buy Volume
€483,917
17 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Shuttle Pharmaceuticals Holdings, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
48Σ signal
Buys €50,766€483,917 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,243 shares@ US$1.605100.0% of flowCOMMON STOCKSEC:0001493152-22-037141:0
23 of 23 declarations
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc. is a company focused on developing innovative pharmaceutical treatments. It specializes in researching and commercializing therapeutic solutions for serious diseases.